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ABSTRACT  We have previously shown that in confluent human fibroblast cultures chondroitin sulfate 
proteoglycan is a component of the fibronectin-containing  pericellular  matrix fibers.  In the present 
work the distribution of chondroitin sulfate was studied in subconfluent cell cultures using antibodies 
that bind to a chemically defined carbohydrate fragment of chondroitinase ABC-modified chondroitin 
sulfate  proteoglycan. Using immunofluorescence  microscopy, we observed, in addition to the fibrillar 
matrix staining,  chondroitin sulfate  diffusely distributed at the cell surface.  In indirect immunoferritin 
electron  microscopy  this  staining corresponded  to  patchy  binding of ferritin  close  (24  nm) to the 
outer aspect of the plasma membrane. The patchy organization appeared uniform in all cell surfaces. 
The cell  surface  chondroitin  sulfate  could  not  be removed  from  the  plasma  membrane  by agents 
that dissociate electrostatic  interactions.  These data show that in fibroblasts chondroitin  sulfate  is a 
component  of the  outer aspect  of the  plasma  membrane,  and  raise the  possibility  of an  integral 
plasma membrane chondroitin sulfate  proteoglycan. 
The  surfaces  of cultured  fibroblasts  are  composed  of the 
plasma  membrane  and  the  pericellular matrix.  The  latter 
forms a fibrillar network, the major constituents of which are 
fibronectin (1, 2), procollagen a-chains (3, 4), and later col- 
lagen (5), other glycoproteins (6, 7), and sulfated proteogly- 
cans (8, 9). The fibronectin fibers are in close association with 
cytoplasmic actin microfilaments at places (1,  10,  11). Such 
fibronexuses are preferentially located close to focal contacts 
or adhesions (12-16) between the cell and the growth substra- 
tum, particularly in low serum concentrations (11,  17). The 
role of fibronectin in  fibroblast attachment, spreading and 
locomotion is widely accepted; how these functions relate to 
the genesis of matrix fibers is not clear. Heparan sulfate (HS)  ~ 
has been  hypothesized to stabilize  the  focal adhesion sites 
whereas chondroitin sulfate (CS) was suggested to destabilize 
them (18).  Exogenous CS proteoglycans did, indeed, inhibit 
fibronectin-mediated cell adhesion to collagen (19). There is 
also in vitro evidence for differing functions of HS and CS in 
relation to fibronectin-collagen fibrillogenesis (20). These data 
have prompted us to study the distributions of external pro- 
teoglycans. We have previously shown that HS and CS pro- 
teoglycans are components of the pericellular matrix fibers, 
Abbreviations used in this paper,  cABC, chondroitinase ABC; cAC, 
chondroitinase  AC;  CS,  chondroitin  sulfate;  HS,  heparan  sulfate; 
HES,  human  embryonic  fibroblasts;  DME-BSA,  Dulbecco's  mini- 
mum essential medium-BSA. 
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in  firm  association  with  the  polypeptide backbone  of the 
matrix (9). However, in isolated pericellular matrices, insol- 
uble CS was  also  present beside the  fibronectin-containing 
matrix fibers (9). Here we have defined the location of this 
cell surface component. Antibodies were produced against a 
chemically defined carbohydrate fragment of CS. This anti- 
gen, and unsaturated oligosaccharide, is generated by diges- 
tion of chondroitin-4-sulfate proteoglycan with chondroitin- 
ase ABC and remains covalently bound to the proteoglycan 
core (21). 
MATERIALS  AND  METHODS 
Cell Cultures:  Human embryonic flbroblasts  (HES) of local origin or 
murine 3T3 cells were grown on plastic dishes with or without glass coverslips, 
as previously described (l). The cells were used for the experiments at subcon- 
fluent densities, 5-48 h after subculture. For immunoenzymatic quantitation 
of  cell surface chondroitin sulfate, HES cells were seeded into 96-well microtitcr 
plates (Linbro/FIow, Hamden, CO) and were used 24 h after seeding. 
ImmunocytochemicaI  Staining for Chondroitin Sulfate:  cs 
was rendered antigenic to our antibody by treatment of living or fixed cell 
layers with chondroitinase ABC (cABC) or, for comparison, with chondroitinase 
AC (cAC) (Seikagaku  Kogyo, Tokyo, Japan): live cells were briefly rinsed three 
times at 37°C with Dulbecco's minimum essential medium containing 2 rag/ 
ml BSA, penicillin,  and streptomycin (DME-BSA).  The cultures were digested 
with 5-50 mU/ml of cABC or with 50-500 mU/ml of cAC in DME-BSA for 
30 min at 37°C, rinsed three times with DME-BSA followed by Pi,rNaCl (0.01 
M sodium phosphate, 0.14 M NaCl, pH 7.4), and fixed with 4% paraformal- 
dehyde or with 1% glutaraldehyde for immunofluorescence  or immunoferritin 
staining, respectively.  Alternatively,  rinsed cell cultures were first fixed, rinsed, 
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For  comparison, in  some experiments the enzyme treatment of fixed cell 
cultures took place in 0.1  M Tris-HCl, pH 8.0, containing 1 mM EDTA, 0.8 
M N--ethylmaleimide, and 0.2 mM phenylmethyisulfonyl  fluoride as proteinase 
inhibitors, for  16 h at 40C. The two different digestion buffers gave identical 
immunofluorescence  results. The digested, fixed cell cultures were then stained 
for the antigenic unsaturated oligosaccharides of CS using rabbit antiserum 
(21) diluted 1:100 in PBS for 30 rain, and were subsequently  rinsed three times 
for 10 min. The cultures were  treated with antirabbit IgG-FITC (Wellcome, 
Bcckenham, England;  1:20  in  PBS)  or with antirabbit  lgG-ferritin (Cappel 
Laboratories, Cochranville, PA; 1:50 in Pi/NaCl) conjugates for 30 or 60 rain, 
for  immunofluorescence or  immunoelectron microscopy, respectively.  The 
rinsed samples on coverslips were mounted for immunofluo~cence, observed 
and photographed as described (I). Immunoferritin-stained  samples on plastic 
were fixed with 2%  glutaraldehyde and processed for transmission electron 
microscopy (l). Thin sections were  poststained with uranyl acetate and lead 
citrate and were observed and photographed in a  Jeol  100 CX TEMSCAN 
electron microscope operated at 60 kV at the Department of Electron Micros- 
copy, University of Helsinki, Finland. 
Staining Controls:  Preimmune serum of  the same rabbit (bled at the 
time of first immunization) diluted l:100 was allowed to stain cell cultures as 
above.  A  blocking control was carried  out by adding to  the diluted (l:10) 
immune antiserum 4-500 #g/ml of purified CS hexasaccharide, obtained from 
limited cABC digestion of rat chondrosarcoma proteoglycan (21), followed  by 
10-fold dilution of the blocked antiserum and immunofluorescence  or immu- 
noferritin staining as above.  As a  control  for the blocking experiments the 
antiserum was treated with purified hexasaccharide produced as described (22) 
from  rooster comb hyaluronic acid.  Cell  cultures were  also  fixed without 
cbondroitinasc treatment and immunofluorescence stained with the immune 
antiserum to show the specificity  for chondroitinase digestion product of the 
results. Finally, two control experiments  were carried out to eliminate artificial 
adsorption to  the cell  surface of antigenic digestion product:  (a)  living cell 
cultures were digested with cABC and the enzyme supernatant was collected 
and heated at  100"C for 5  min to inactivate the chondroitinase. Untreated 
cultures were then incubated in this oligosaccharide-containin$  solution for 30 
rain at 37°C, rinsed, fixed, and stained as described above. (b) Fixed, nondi- 
gested cell cultures were treated with purified CS hexasaccharide  (see above) at 
10 or 100/zg/ml followed by immunofluorescence  staining. 
Stability of Cell Surface  Chondroitin  Sulfate:  Human  fibro- 
blast cultures were rinsed and kept in DME-BSA for 30 min at 37°C or at 4"C 
before fixation. Alternatively, the cell  cultures were  treated with cABC and 
then incubated in DME-BSA for 30 min at 37°C and subsequently fixed. To 
study  the nature of  bonds  joining CS to the cell surface, rinsed cells were treated 
with 0.32 M NaCI or with 0.5- 1.0 mg/ml  ofheparin (Medic,  a, Helsinki, Finland) 
in DME-BSA for 15-30 min at 37°C or at 4°C, or with 0.5 or 5 mM EDTA in 
Pi/NaCI or DME-BSA, respectively,  at 37°C or 4°C. The role of cytoskeletal 
elements was tested by treatment of cells with cytocbalasin B or colchicine (23) 
in DME-BSA. The treated cell cultures were then briefly  rinsed and fixed for 
immunofluorescence  or immunoferdtin electron microscopy. 
To quantitate the possible release  of CS from the cell surface by the above 
treatments, and to assess  the specificity of  the immunostaining  for CS, we used 
enzyme immunoassay (24) briefly  as follows:  human embryonic fibroblasts 
grown in microtiter wells were treated as above, then fixed with 4% parafor- 
maldehyde and treated with 5 or 50 mU/ml of cABC or 50 mU/ml ofcAC for 
45 min at 37"C in DME-BSA. After two washings with DME-BSA the cells 
were surface-treated  with a saturating  concentration of  the anti-CS serum ( 1:100 
dilution in Pi/NaCI containing 5 mg/ml BSA) or with the blocked antisera (see 
above) or the preimmune serum as specificity controls, for 6 h at 20°C. After 
two washings, the samples  were treated with horseradish peroxidase-conjugated 
staphylococcal protein A (24) followed by washing  and the peroxidase substrate. 
Three separate experiments were carried out and each time four parallel  wells 
were used for each reagent tested. 
RESULTS 
Immunofluorescence Localization of Chondroitin 
Sulfate 
Subconfluent cultures  of HES  or 3T3  cells were digested 
with cABC  or cAC  to render  CS antigenic to our antiserum. 
The  cells  were  enzyme  treated  alive  or  after  fixation  with 
paraformaldehyde.  Irrespective  of  the  sequence  of  fixation 
and  enzyme  treatment,  cells stained  with  the  CS  antiserum 
showed a  nearly uniform  surface staining (Fig.  l, a-c). Upon 
focusing,  however,  brighter  patchy  or  "hairy"  fluorescence 
could be resolved on the dorsal cell surface (Fig.  1 a) of spindle- 
shaped  cells (Fig.  1 b),  or in  mitotic  cell  pairs (Fig.  1 c).  The 
fluorescence intensity varied between individual cells. Part of 
the difference could be correlated with cell shape: well-spread 
cells had the weakest apparent  surface fluorescence (Fig.  1 c). 
FIGURE  1  Immunofluorescence staining for cell surface CS. HES cells were fixed with paraformaldehyde  24 h after subculture, 
shortly digested with cABC and treated with rabbit immune antiserum against the unsaturated oligisaccharide of CS (a-c) or with 
the respective  preimmune serum (d), followed by antirabbit IgG-FITC. Focusing on the dorsal surface of a Iocomotory fibroblast, 
a shows a uniform surface fluorescence interrupted by brighter dots and lamellae  at the leading cell edge, to the right (x 720). A 
spindle-shaped cell (b) and a mitotic cell pair (c) are distinguished  from the well spread cells of the background  (x 670 and x 
560, respectively).  Pericellular fibrillar CS staining is also seen (b and c). (d) Control cells stained with preimmune serum (x 800). 
Bars, 20/sm. 
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the  fluorescent surface (Fig.  1,  a-c).  Weak fluorescence for 
CS was also found in pericellular matrix fibers,  which could 
be double-stained  with  rhodamine-conjugated  sheep antifi- 
bronectin  (previously  shown  in  reference  9).  This  matrix 
fluorescence  was  usually  seen  at  the  sites where  local  cell 
density approached confluence and seemed to appear in the 
matrix fibers later than that of fibronectin. 3T3 cells gave cell 
surface fluorescence very similar to that  of HES (data  not 
shown). 
Specificity controls included staining of cABC-treated cells 
with preimmune serum, or staining of cells with the immune 
serum without prior enzyme treatment. These controls gave 
only negligible  faint background  fluorescence over the  cell 
bodies and  none in the pericellular matrix (Fig.  1  d).  Addi- 
tionally,  blocking  controls  were  carried  out  in  which  the 
immune serum was mixed with various amounts of purified 
unsaturated hexasaccharide obtained from limited chondroi- 
tinase  treatment  of chondrosarcoma CS.  Such  blocking  is 
known to inhibit the reactivity of our antiserum with chon- 
drosarcoma CS  proteoglycan (21).  Here,  100  ~g/ml of the 
hexasaccharide completely eliminated the cell surface fluores- 
cence,  whereas  4  gg/ml  was  partially  active.  Comparable 
attempts to block the staining using antibodies preadsorbed 
with  unsaturated  oligosaccharides from HA  or with  intact 
heparin did not diminish the immunofluorescence intensity 
(not illustrated, cf.  Fig.  6).  Finally, since antigenic oligosac- 
charides might have been solubilized and rebound during the 
chondroitinase treatment, another set of control experiments 
was carried out.  For this purpose, cABC supernatants were 
collected from live-digested cell cultures, the enzyme activity 
was destroyed by boiling and  untreated  rinsed cell cultures 
were incubated in  the antigenic digests.  Alternatively, fixed 
cell layers were treated with antigenic purified hexasaccharide 
of CS.  When such control samples were stained, no fluores- 
cence above background  was observed.  These experiments 
excluded artificial binding from the  digestion buffer to the 
surfaces of antigenic material. 
Immunoferritin Electron Microscopy 
The immunofluorescence results suggested presence of CS 
at the fibroblast surfaces, thus warranting further immunolo- 
calization at  the  ultrastructural  level.  HES fibroblasts were 
treated with cABC before or after glutaraldehyde fixation and 
immunoferritin stained  for surface CS.  Preliminary experi- 
ments using immunoperoxidase staining at the light micro- 
scopic level showed that the used glutaraldehyde prefixation 
gave  CS  staining  patterns  identical  to  that  obtained  after 
paraformaldehyde prefixation (data not shown). After diges- 
tion of prefixed cell layers, ferritin was seen bound to the cell 
surface (Fig. 2). The mean distance of ferritin cores from the 
outer surface of  the plasma membrane, as measured from 100 
ferritin  particles  above a  perpendicularly  sectioned  plasma 
membrane, was 23.8  nm. The same ferritin distribution was 
obtained whether  fixed or unfixed  cells were digested with 
cABC,  and  was  present  also  when  live-digested cells  were 
immunostained and  washed alive at 4"C  and  subsequently 
fixed. The amount of ferritin bound per length unit along the 
plasma membranes varied between different cells,  but  in  a 
given cell appeared similar in different locations of the cell 
surface. The distribution  of individual ferritin particles was, 
however, not random: the particles seemed to be arranged in 
patches. Since the observed ultrastructural patchy distribution 
of CS in the one dimension of sectioned cell surface could be 
derived from either patchy or  reticular  organization  at  the 
plasma membrane, it was important to find electron micro- 
scope sections tangential with and close to the outer surface 
of the  membrane. In such  micrographs ferritin was clearly 
seen  arranged  in  patches,  the  organization  of which  was 
random in  a  given cell surface area (Fig.  3).  Each "patch" 
comprised 1-30 ferritin particles and was separated from the 
adjacent one by a  gap of 0-500  nm,  average  100-200  nm 
(Fig.  3).  The  specificity  controls,  preimmune  serum  after 
cABC as well as immune serum without preceding enzyme 
treatment, gave virtually no binding of ferritin to the plasma 
membrane  and  only  occasional  binding  of ferritin  to  the 
FIGURE 2  Immunoferritin electron microscope staining for CS at the surface of human fibroblasts.  The cells were fixed with 
glutaraldehyde, digested  with cABC,  and  treated with antiserum  against the unsaturated  oligosaccharide  of CS, followed by 
ferritin-conjugated anti-lgG. Ferritin is bound close to the plasma membrane (arrow). Uranyl acetate-lead citrate poststaining. Bar, 
500 nm. x  66,000. 
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surface  including parts of the cortical cytoplasm (C), fuzzy zone indicating plasma membrane (P), and the extracellular space (E). 
Ferritin is distributed in patches of 1 to 30. Bar, 500 nm. ×  52,000. 
pericellular matrix. When the immune serum was adsorbed 
with  100 ug/ml of unsaturated hexasaccharide of CS,  nearly 
all ferritin was removed from the plasma membrane (Fig. 4). 
Stability of CS-Cell Surface Association 
To  study the  nature  of association  between  CS  and  the 
plasma membrane,  HES fibroblasts were first incubated  in 
DME-BSA for 30 min at 37°C or at 4"C. Whether the incu- 
bation took place before or after chondroitinase, the immu- 
nofluorescence results were qualitatively and  quantitatively 
indistinguishable  from those described above. The cell  cul- 
tures  were  exposed  to  various  reagents:  EDTA  treatment 
rounded up the cells, with concomitant apparent intensifica- 
tion  of cell  surface  immunofluorescence.  NaCI  or  heparin 
removed little or no CS from the plasma membrane. Colchi- 
cine gave results very similar to that of EDTA. Treatment of 
the cells with cytochalasin B caused dramatic "arborization" 
(23) of cell bodies with no apparent change in the degree of 
surface fluorescence.  Estimations of plasma membrane im- 
munofluorescence intensities after the various treatments of 
the cells are summarized in Table I. The inability of EDTA 
or heparin to deplete cell surfaces of immunoreactive CS was 
further documented by immunoelectron microscopy. EDTA- 
treated  (Fig.  5)  or  heparin-treated  (not  illustrated)  cellular 
plasma membranes bound ferritin conjugates at an apparently 
unaltered density. 
Because of the semiquantitative nature of immunofluores- 
cence, the ability of the chemicals to remove CS from the cell 
surface, and the specificity for CS of the antibody binding was 
further analyzed in  situ in the cell cultures using an immu- 
noenzyme assay. Cells grown in plastic microwells were di- 
gested with cABC or cAC,  with or without prior treatment 
with  EDTA,  NaC1,  heparin,  colchicine,  cytochalasin  B,  or 
Nonidet  P-40,  followed by immunoenzymatic quantitation 
of external CS. As summarized in Table II, NaCI, heparin, or 
colchicine had no effect on the amount of immunoreactive 
CS.  Cytochalasin B and Nonidet P-40 at 0.01%  diminished 
immunoreactivity slightly.  EDTA detached  50-90%  of the 
FIGURE  4  Blocking control for immunoferritin staining. The diluted 
immune antiserum was mixed with  100 #glml of purified unsatu- 
rated hexasaccharide  obtained from cartilage CS and was then used 
in immunoferritin staining of cABC-treated human fibroblasts. One 
ferritin particle (arrowhead) is seen. Bar, 200 nm. x  56,000. 
TABLE  I 
Stability of CS at the Cell Surface as Measured by 
Immunofluorescence Microscopy 
Estimated immunofluorescence 
Chemical  intensity 
cABC, 50 mU/ml  +++ 
cABC, 5 mU/ml  +++ 
cAC, 50 mU/ml  + 
No enzyme  (+) 
Preceding enzyme 
NaCI, 0.32 M  ++(+) 
Heparin, 1 mg/ml  ++(+) 
Colchicine, 10 M  +++ 
Cytochalasin B, 3 ~g/ml  +++ 
EDTA, 0.5 mM  +++ 
Nonidet P-40, 0.1%  No cells 
Nonidet P-40, 0.01%  ++ 
Other treatments  in MEM-BSA except for EDTA, which was in Pi/NaCI. 
cells from the plastic, and Nonidet P-40 at 0.1% solubilized 
the cells. To exclude the remote possibility that the antibodies 
bound digestion products of HA (which is a substrate for the 
chondroitinases) the antiserum was pretreated with unsatu- 
rated  HA  oligosaccharides,  and  the  binding  inhibition  was 
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with 0.5  mM EDTA in  Pi/NaCl  for 30  min at 4°C, fixed, digested 
with cABC, and immunoferritin stained for CS. Ferritin decorates a 
microvillus and the cell surface.  Bar, 200 nm. x  37,000. 
TABLE  II 
Stability of CS at the Cell Surface as Measured by Enzyme 
Immunoassay 
Percentage 
Chemical  from control  Significance 
Pip)  (P) 
cABC 50 mU/ml  100 
cABC 5 mO/ml  81  <0.05 
cAC 50 mU/ml  48  <0.001 
No enzyme  6  <0.001 
Preceding cABC (50 
mU/ml): 
NaCI, 0.32 M 
heparin, 1.0 mg/ml 
colchicine, 10 ~M 
cytochalasin B, 3 ~tg/ 
ml 
EDTA, 5 mM 
98  ns 
99  ns 
102  ns 
81  <0.01 
66 
Nonidet P-40, 0.1%  63 
Nonidet P-40, 0.01%  87 
<0.005 detachment of 
most cells 
<0.005 solubilization of 
cells 
<0.05 
Cells treated with cABC (50 mUlml) are indicated as 100% and serve as the 
comparison group. The percentages are calculated from absorbance ratios 
obtained in enzyme immunoassay. Background  values obtained from preim- 
mune serum were subtracted from the calculation. The figures are the mean 
of 15 microwel[s. Difference  to comparison group is calculated using Stu- 
dent's t test. ns, not significant. 
compared to that of  the unsaturated CS oligosaccharides using 
immunoenzyme assay. As shown in Fig. 6, only CS oligosac- 
charides were able to block the antibodies.  That this was not 
due to nonspecific electrostatic  interaction  is  shown by the 
inability of heparin to inhibit the binding (Fig. 6). 
DISCUSSION 
Cultured rat yolk sac tumor cells were recently shown to have 
a diffuse distribution of CS proteoglycan at the "cell surface" 
using immunofluorescence microscopy and antibodies raised 
to  the  protein  domain  (24).  In the  present  work we show, 
using immunofluorescence and immunoferritin electron mi- 
croscopy, that fibroblasts have CS at the outer surface of  their 
plasma membrane. The antigen recognized by our antibodies 
is  a  chemically defined  oligosaccharide generated  by cABC 
specifically from the  carbohydrate chains  of chondroitin-4- 
sulfate-containing proteoglycans (21).  As  CS  proteoglycans 
are  major components secreted  into  the  medium by fibro- 
blasts, it was important to study the duration and quality of 
the CS-plasma membrane association. The antigenic CS could 
be removed neither by incubation of the cells for 30 min in 
fresh  culture  medium  nor using  EDTA,  NaC1,  or heparin. 
The  results  suggest a  relatively long half-life  at  the  plasma 
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INHIBITOR  (t~lllml) 
FtGUrE  6  Blocking  con- 
trol by immunoenzyme  as- 
say. The  immune  antise- 
rum  diluted  1:10  was 
mixed  with  various  con- 
centrations of heparin (1), 
unsaturated  hexasacchar- 
ide of hyaluronic acid (2), 
or  unsaturated  hexasac- 
charide  of  CS  (3),  kept 
overnight at  4°C,  diluted 
further  1:10,  and  allowed 
to stain  cABC-treated cell 
cultures in an indirect immunoenzyme assay. Background is shown 
as the absorbance using preimmune serum (PRE). 
membrane, at least of a  modified antigen, and indicate that 
forces stronger than those of ionic interaction join the mole- 
cule  to  the  membrane.  This  again  points  to  that  the  CS- 
containing  molecule  has  strong,  receptor-like  interactions 
with the periphery of the plasma membrane, or, most inter- 
estingly,  that  it  would  itself  occur  as  an  integral  plasma 
membrane  component.  There  is  evidence  that  hepatocytes 
have a relatively small molecular weight HS proteoglycan as 
an integral plasma membrane component (26). A small frac- 
tion of such cell surface HS proteoglycan could be removed 
by exogenous heparin (26, 27). 
Although  not  shown,  the  external  CS  described  in  the 
present work conceivably belongs to a proteoglycan. Cultured 
fibroblasts seem to produce at least two types of CS proteo- 
glycan (28); the larger contains CS types A  and C, whereas 
the smaller is rich in CS type B (dermatan sulfate).  The fact 
that cAC-treated cell  surfaces reacted  only weakly with our 
antiserum  could  be  due  to  two  reasons:  (a)  The  antigenic 
molecules were mostly CS type B (dermatan  sulfate), which 
contains chondroitin-4-sulfate, and is not a substrate of cAC. 
(b) The antibodies preferred cABC-digested cell surfaces over 
the cAC-digested ones because cAC is known to degrade CS 
down to a  short linkage  oligosaccharide,  which reacts only 
minimally with our antiserum (21). Thus, although we con- 
vincingly showed that  the  reactive  molecule  at  the  plasma 
membrane was CS, it is not yet clear which of the CS types 
was responsible for the antibody binding. 
We have previously shown that fibronectin, a  pericellular 
matrix  glycoprotein, is  found at  places in  close association 
with the plasma membrane  (1).  Even then,  using the same 
indirect  immunoferritin  procedure,  the  distance  of ferritin 
particles from the lipid bilayer was longer than in the present 
case (24 nm) of cell surface CS. These data are permissive for 
the idea that the CS is part of  a plasma membrane component. 
The  CS-bound  ferritin  particles  had  a  patchy  distribution 
uniformly at  all  cell  surfaces,  quite  unlike  fibronectin,  HS 
proteoglycan, and other pericellular matrix components. The 
simplest explanation for the observed CS-ferritin distribution 
would  be  lateral  mobility  at  the  plasma  membrane.  Such 
features are characteristic for a class of integral plasma mem- 
brane components. 
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